Quantitative anti-p24 determinations can predict the risk of vertical transmission. Swiss HIV and Pregnancy Collaborative Study Group

J Acquir Immune Defic Syndr (1988). 1994 Mar;7(3):261-4.

Abstract

Quantitative serum antibody to p24 was evaluated as a predictor of risk of vertical transmission of human immunodeficiency virus type 1 (HIV-1) infection. HIV-positive mothers, 13 with HIV-infected children and 24 with noninfected children were investigated during pregnancy and at the time of delivery. A statistically significant difference in anti-p24 titers was found between the mothers with infected and those with noninfected children independent of whether antibodies were measured during pregnancy or at the time of delivery. High anti-p24 levels correlated with a low risk of vertical transmission, whereas low anti-p24 titers were associated with an increased risk of vertical transmission. Although the number of CD4+ T-cells was lower and neopterin and beta-2 microglobulin values were higher in the group of mothers with infected children than in the noninfected group, no statistical significance was achieved due to the small sample size.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopterins / analogs & derivatives
  • Biopterins / blood
  • CD4-Positive T-Lymphocytes
  • Female
  • HIV Envelope Protein gp41 / blood*
  • HIV Infections / transmission*
  • HIV-1*
  • Humans
  • Infant, Newborn
  • Leukocyte Count
  • Neopterin
  • Pregnancy
  • Pregnancy Complications, Infectious*
  • Prognosis
  • Risk Factors
  • beta 2-Microglobulin / analysis

Substances

  • HIV Envelope Protein gp41
  • beta 2-Microglobulin
  • Biopterins
  • Neopterin